Skip to main content
. 2008 Jun;152(3):456–463. doi: 10.1111/j.1365-2249.2008.03650.x

Table 2.

Unstimulated T helper 1 (Th1)- and Th2-producing CD4+ and CD8+ T-cells from peripheral blood of ischaemic stroke patients and controls.

Cytokine Group CD4+ T cells (%) P-value* CD8+ T cells (%) P-value*
IFN-γ MC 0·06 ± 0·04 n.s. 0·09 ± 0·05 n.s.
ISs- 0·08 ± 0·04 0·11 ± 0·04
ISs+ 0·10 ± 0·05 0·09 ± 0·02
IL-2 MC 0·18 ± 0·10 n.s. 0·17 ± 0·10 n.s.
ISs- 0·15 ± 0·09 0·18 ± 0·15
ISs+ 0·16 ± 0·09 0·17 ± 0·11
IL-4 MC 0·09 ± 0·04 n.s. 0·08 ± 0·03 n.s.
ISs- 0·12 ± 0·06 0·16 ± 0·15
ISs+ 0·13 ± 0·07 0·17 ± 0·14
IL-10 MC 0·27 ± 0·14 n.s. 0·43 ± 0·22 n.s.
ISs- 0·22 ± 0·19 0·34 ± 0·31
ISs+ 0·29 ± 0·29 0·29 ± 0·23

Whole blood was cultured for 5 h in plain medium in the presence of brefeldin A. The values of cytokine-producing cells were calculated as the percentage of CD4+ and CD8+ peripheral T cells. Data are expressed as mean ± standard deviation.

*

P-values refer to the comparison between the three study groups (MC, ISs -, ISs+) using one-way analysis of variance test. IL, interleukin; IFN, interferon; ISs-, ischaemic stroke patients not receiving statins (n = 17); ISs+, IS patients receiving statins (n = 6); MC, matched controls (n = 7); n.s., not statistically significant.